Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials

Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials

Item
http://www.wikidata.org/entity/Q34447938
Cardiovascular side effects of atomoxetine and its interactions with inhibitors of the cytochrome p450 systemAssociations between psychiatric comorbidities and sleep disturbances in children with attention-deficit/hyperactivity disorder.Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorderFunctional Connectivity of Child and Adolescent Attention Deficit Hyperactivity Disorder Patients: Correlation with IQ.Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries.Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder, based on a pooled analysis.The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research.ADHD Symptoms and Quality of Life Across a 12-Month Period in Children With ADHD: A Longitudinal Study.Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder.Participant-perceived quality of life in a long-term, open-label trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Adults With ADHD.Health-related quality of life in ADHD: a pooled analysis of gender differences in five atomoxetine trials.
P2860

Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials

Item
http://www.wikidata.org/entity/Q34447938
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Differences between children a ...... sis of five atomoxetine trials
@ast
Differences between children a ...... sis of five atomoxetine trials
@en
Differences between children a ...... sis of five atomoxetine trials
@nl
type
label
Differences between children a ...... sis of five atomoxetine trials
@ast
Differences between children a ...... sis of five atomoxetine trials
@en
Differences between children a ...... sis of five atomoxetine trials
@nl
prefLabel
Differences between children a ...... sis of five atomoxetine trials
@ast
Differences between children a ...... sis of five atomoxetine trials
@en
Differences between children a ...... sis of five atomoxetine trials
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Differences between children a ...... sis of five atomoxetine trials
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932